Clinically Collected Esophageal Cancer Whole Blood for Biomarker Research

Esophageal Cancer Whole Blood is obtained from IRB-consented donors with a confirmed diagnosis of esophageal cancer, including adenocarcinoma and squamous cell subtypes. Ideal for blood-based biomarker research, tumor-immune interaction studies, and immuno-oncology applications.

Product Features

• Collected from donors with confirmed esophageal cancer
• Fresh or frozen whole blood preserved with anticoagulant
• Supports translational and clinical oncology research
• Customizable donor and collection specifications

Donor Metadata

• Diagnosis, subtype, and cancer stage
• Demographics: age, sex, ethnicity
• Treatment history and comorbidities when available

Applications

• Liquid biopsy assay development
• Immuno-oncology and checkpoint research
• Cancer progression and response monitoring

Compliance and Quality Assurance

• Collected under IRB-approved protocols
• Informed consent and HIPAA-compliant data handling
• Documented quality control processes

Ordering & Customization

Esophageal Cancer Whole Blood is available fresh or frozen. Paired biospecimens and custom collection protocols available on request. Contact [email protected] to discuss your project needs.